Used in pharmaceutical research as a key intermediate in the development of targeted therapies, particularly in oncology. Its structure supports binding to specific enzyme targets involved in cell signaling pathways, making it valuable in the design of kinase inhibitors. The compound's functional groups enable conjugation and prodrug strategies, enhancing bioavailability and tissue targeting. It is also explored in antibody-drug conjugates (ADCs) due to its reactive handle for linker attachment, allowing precise delivery of cytotoxic agents to cancer cells.